Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length

Huntington's disease (HD) is caused by CAG triplet repeat expansion inIT15which leads to polyglutamine stretches in the HD protein product, huntingtin. The pathological hallmark of HD is the degeneration of subsets of neurons, primarily those in the striatum and neocortex. Specific morphologica...

Full description

Bibliographic Details
Main Authors: Mark W. Becher, Joyce A. Kotzuk, Alan H. Sharp, Stephen W. Davies, Gillian P. Bates, Donald L. Price, Christopher A. Ross
Format: Article
Language:English
Published: Elsevier 1998-01-01
Series:Neurobiology of Disease
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996198901681
id doaj-752dd6562367466680a45503efc413c8
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Mark W. Becher
Joyce A. Kotzuk
Alan H. Sharp
Stephen W. Davies
Gillian P. Bates
Donald L. Price
Christopher A. Ross
spellingShingle Mark W. Becher
Joyce A. Kotzuk
Alan H. Sharp
Stephen W. Davies
Gillian P. Bates
Donald L. Price
Christopher A. Ross
Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length
Neurobiology of Disease
author_facet Mark W. Becher
Joyce A. Kotzuk
Alan H. Sharp
Stephen W. Davies
Gillian P. Bates
Donald L. Price
Christopher A. Ross
author_sort Mark W. Becher
title Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length
title_short Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length
title_full Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length
title_fullStr Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length
title_full_unstemmed Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length
title_sort intranuclear neuronal inclusions in huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions andit15cag triplet repeat length
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 1998-01-01
description Huntington's disease (HD) is caused by CAG triplet repeat expansion inIT15which leads to polyglutamine stretches in the HD protein product, huntingtin. The pathological hallmark of HD is the degeneration of subsets of neurons, primarily those in the striatum and neocortex. Specific morphological markers of affected cells have not been identified in patients with HD, although a unique intranuclear inclusion was recently reported in neurons of transgenic animals expressing a construct encoding the N-terminal part (including the glutamine repeat) of huntingtin (Davieset al., 1997). In order to understand the importance of this finding, we sought for comparable nuclear abnormalities in autopsy material from patients with HD. In all 20 HD cases examined, anti-ubiquitin and N-terminal huntingtin antibodies identified intranuclear inclusions in neurons and the frequency of these lesions correlated with the length of the CAG repeat inIT15. In addition, examination of material from the related HD-like triplet repeat disorder, dentatorubral and pallidoluysian atrophy, also revealed intranuclear neuronal inclusions. These findings suggest that intranuclear inclusions containing protein aggregates may be a common feature of the pathogenesis of glutamine repeat neurodegenerative disorders.
url http://www.sciencedirect.com/science/article/pii/S0969996198901681
work_keys_str_mv AT markwbecher intranuclearneuronalinclusionsinhuntingtonsdiseaseanddentatorubralandpallidoluysianatrophycorrelationbetweenthedensityofinclusionsandit15cagtripletrepeatlength
AT joyceakotzuk intranuclearneuronalinclusionsinhuntingtonsdiseaseanddentatorubralandpallidoluysianatrophycorrelationbetweenthedensityofinclusionsandit15cagtripletrepeatlength
AT alanhsharp intranuclearneuronalinclusionsinhuntingtonsdiseaseanddentatorubralandpallidoluysianatrophycorrelationbetweenthedensityofinclusionsandit15cagtripletrepeatlength
AT stephenwdavies intranuclearneuronalinclusionsinhuntingtonsdiseaseanddentatorubralandpallidoluysianatrophycorrelationbetweenthedensityofinclusionsandit15cagtripletrepeatlength
AT gillianpbates intranuclearneuronalinclusionsinhuntingtonsdiseaseanddentatorubralandpallidoluysianatrophycorrelationbetweenthedensityofinclusionsandit15cagtripletrepeatlength
AT donaldlprice intranuclearneuronalinclusionsinhuntingtonsdiseaseanddentatorubralandpallidoluysianatrophycorrelationbetweenthedensityofinclusionsandit15cagtripletrepeatlength
AT christopheraross intranuclearneuronalinclusionsinhuntingtonsdiseaseanddentatorubralandpallidoluysianatrophycorrelationbetweenthedensityofinclusionsandit15cagtripletrepeatlength
_version_ 1724206803039813632
spelling doaj-752dd6562367466680a45503efc413c82021-03-23T04:11:45ZengElsevierNeurobiology of Disease1095-953X1998-01-0146387397Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat LengthMark W. Becher0Joyce A. Kotzuk1Alan H. Sharp2Stephen W. Davies3Gillian P. Bates4Donald L. Price5Christopher A. Ross6Department of Pathology, Division of Neuropathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Program in Cellular and Molecular Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Department of Anatomy and Developmental Biology, University College London, London, WC1E 6BT, United Kingdom; Division of Medical and Molecular Genetics, UMDS, Guy's Hospital, London, SE1 9RT, United KingdomDepartment of Pathology, Division of Neuropathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Program in Cellular and Molecular Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Department of Anatomy and Developmental Biology, University College London, London, WC1E 6BT, United Kingdom; Division of Medical and Molecular Genetics, UMDS, Guy's Hospital, London, SE1 9RT, United KingdomDepartment of Pathology, Division of Neuropathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Program in Cellular and Molecular Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Department of Anatomy and Developmental Biology, University College London, London, WC1E 6BT, United Kingdom; Division of Medical and Molecular Genetics, UMDS, Guy's Hospital, London, SE1 9RT, United KingdomDepartment of Pathology, Division of Neuropathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Program in Cellular and Molecular Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Department of Anatomy and Developmental Biology, University College London, London, WC1E 6BT, United Kingdom; Division of Medical and Molecular Genetics, UMDS, Guy's Hospital, London, SE1 9RT, United KingdomDepartment of Pathology, Division of Neuropathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Program in Cellular and Molecular Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Department of Anatomy and Developmental Biology, University College London, London, WC1E 6BT, United Kingdom; Division of Medical and Molecular Genetics, UMDS, Guy's Hospital, London, SE1 9RT, United KingdomDepartment of Pathology, Division of Neuropathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Program in Cellular and Molecular Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Department of Anatomy and Developmental Biology, University College London, London, WC1E 6BT, United Kingdom; Division of Medical and Molecular Genetics, UMDS, Guy's Hospital, London, SE1 9RT, United KingdomDepartment of Pathology, Division of Neuropathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Division of Neuropathology, Program in Cellular and Molecular Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205-2196; Department of Anatomy and Developmental Biology, University College London, London, WC1E 6BT, United Kingdom; Division of Medical and Molecular Genetics, UMDS, Guy's Hospital, London, SE1 9RT, United KingdomHuntington's disease (HD) is caused by CAG triplet repeat expansion inIT15which leads to polyglutamine stretches in the HD protein product, huntingtin. The pathological hallmark of HD is the degeneration of subsets of neurons, primarily those in the striatum and neocortex. Specific morphological markers of affected cells have not been identified in patients with HD, although a unique intranuclear inclusion was recently reported in neurons of transgenic animals expressing a construct encoding the N-terminal part (including the glutamine repeat) of huntingtin (Davieset al., 1997). In order to understand the importance of this finding, we sought for comparable nuclear abnormalities in autopsy material from patients with HD. In all 20 HD cases examined, anti-ubiquitin and N-terminal huntingtin antibodies identified intranuclear inclusions in neurons and the frequency of these lesions correlated with the length of the CAG repeat inIT15. In addition, examination of material from the related HD-like triplet repeat disorder, dentatorubral and pallidoluysian atrophy, also revealed intranuclear neuronal inclusions. These findings suggest that intranuclear inclusions containing protein aggregates may be a common feature of the pathogenesis of glutamine repeat neurodegenerative disorders.http://www.sciencedirect.com/science/article/pii/S0969996198901681